netFormulary
 Report : A-Z HCD items in Formulary 18/04/2021 21:51:03
[Back]
 
Section Status Black Triangle Name
08.01.05 Formulary Black Triangle Abemaciclib Verzenios®
03.01.02 Formulary Black Triangle Aclidinium Eklira Genuair®
03.01.04 Formulary Black Triangle Aclidinium and formoterol  Duaklir Genuair®
08.01.05 Formulary Black Triangle Alectinib Alecensa®
08.01.05 Non Formulary Black Triangle Alpelisib Piqray®
10.01.03 Formulary Black Triangle Apremilast 
13.05.03 Formulary Black Triangle Apremilast 
10.02 Formulary Black Triangle Ataluren Translarna®
09.01.04 Formulary Black Triangle Avatrombopag Doptelet®
08.01.05 Formulary Black Triangle Avelumab Bavencio®
10.01.03 Formulary Black Triangle Baricitinib Olumiant®
13.05.03 Formulary Black Triangle Baricitinib Olumiant®
05.01.09 Formulary Black Triangle Bedaquiline Sirturo®
10.01.03 Formulary Black Triangle Belimumab Benlysta®
03.04.02 Formulary Black Triangle Benralizumab Fasenra®
03.04.03 Formulary Black Triangle Berotralstat 
08.01.05 Formulary Black Triangle Brigatinib Alunbrig®
11.08.02 Formulary Black Triangle Brolucizumab Beovu®
09.08.01 Formulary Black Triangle Burosumab Crysvita®
03.04.03 Formulary Black Triangle C1 esterase inhibitor Cinryze®
02.09 Non Formulary Black Triangle Cangrelor Kengrexal®
05.01.02.01 Formulary Black Triangle Ceftazidime/avibactam 
08.02.04 Formulary Black Triangle Cemiplimab Libtayo
08.01.05 Formulary Black Triangle Ceritinib 
02.06.04 Non Formulary Black Triangle Cilostazol 
14.04 Formulary Black Triangle COVID-19 Vaccine 
05.03.03.02 Formulary Black Triangle Daclatasvir  
08.01.05 Formulary Black Triangle Dacomitinib  Vizimpro®
08.01.05 Formulary Black Triangle Daratumumab Darzalex®
08.03.04.02 Formulary Black Triangle Darolutamide  Nubeqa®
05.03.03.02 Formulary Black Triangle Dasabuvir 
05.01.09 Formulary Black Triangle Delamanid Deltyba®
08.01.05 Formulary Black Triangle Dinutuximab beta Qarziba®
05.03.01 Formulary Black Triangle Dolutegravir sodium/rilpivirine hydrochloride Juluca®
03.04.02 Non Formulary Black Triangle Dupilumab Dupixent®
13.05.03 Formulary Black Triangle Dupilumab Dupixent®) (dermatology
08.01.05 Formulary Black Triangle Durvalumab Imfinzi®
02.08.02 Formulary Black Triangle Edoxaban Lixiana®
05.03.03.02 Formulary Black Triangle Elbasvir with grazoprevir Zepatier®
03.07 Restricted Use Black Triangle Elexacaftor/tezacaftor/ivacaftor Kaftrio®
08.01.05 Formulary Black Triangle Encorafenib Braftovi®
08.01.05 Formulary Black Triangle Entrectinib Rozlytrek®
04.07.04.02 Formulary Black Triangle Erenumab Amiovig®
06.01.02.03 Formulary Black Triangle Ertugliflozin 
10.01.03 Formulary Black Triangle Filgotinib Jyseleca®
03.02 Formulary Black Triangle Fluticasone /umeclidinium / vilanterol Trelegy Ellipta®
04.07.04.02 Formulary Black Triangle Fremanezumab Ajovy®
04.07.04.02 Formulary Black Triangle Galcanezumab Emgality®
08.01.05 Formulary Black Triangle Gemtuzumab ozogamicin Mylotarg®
08.01.05 Formulary Black Triangle Gilteritinib Xospata®
08.01.05 Non Formulary Black Triangle Glasdegib Daurismo®
05.03.03.02 Formulary Black Triangle Glecaprevir with pibrentasvir Maviret®
03.01.02 Formulary Black Triangle Glycopyrronium Seebri Breezhaler®
03.01.04 Formulary Black Triangle Glycopyrronium and indacaterol Ultibro Breezhaler®
13.08.01 Non Formulary Black Triangle Ingenol mebutate Picato®
09.08.01 Formulary Black Triangle Inotersen Tegsedi®
08.01.05 Formulary Black Triangle Inotuzumab ozogamicin Besponsa®
06.01.01.01 Formulary Black Triangle Insulin aspart fast-acting Fiasp®
06.01.01.02 Formulary Black Triangle Insulin glargine biosimilar Abasaglar®; Semglee®
06.01.01.01 Non Formulary Black Triangle Insulin lispro fast-acting Lyumjev®
06.01.01.01 Non Formulary Black Triangle Insulin lispro fast-acting Lyumjev®
08.01.05 Formulary Black Triangle Isatuximab Sarclisa®
08.01.05 Formulary Black Triangle Ixazomib Ninlaro®
10.01.03 Formulary Black Triangle Ixekizumab Taltz®
13.05.03 Formulary Black Triangle Ixekizumab Taltz®
08.01.05 Formulary Black Triangle Larotrectinib Vitrakvi®
05.03.03.02 Formulary Black Triangle Ledipasvir with sofosbuvir Harvoni®
08.01.05 Formulary Black Triangle Lenvatinib Kisplyx®; Lenvima®
05.03.02.02 Formulary Black Triangle Letermovir Prevymis®
05.01.12 Formulary Black Triangle Levofloxacin Quinsair®
01.06.07 Formulary Black Triangle Linaclotide Constella®
08.01.05 Formulary Black Triangle Lorlatinib Lorviqua®
03.07 Restricted Use Black Triangle Lumacaftor/ivacaftor Orkambi®
09.01.04 Formulary Black Triangle Lusutrombopag Mulpleo®
03.04.02 Formulary Black Triangle Mepolizumab Nucala®
05.01.02.02 Formulary Black Triangle meropenem with vaborbactam Vaborem ®
01.06.06 Non Formulary Black Triangle Methylnaltrexone Relistor®
01.06.06 Formulary Black Triangle Naldemedine Rizmoic®
01.06.06 Formulary Black Triangle Naloxegol Moventig ®
08.01.05 Formulary Black Triangle Neratinib Nerlynx®
08.01.05 Formulary Black Triangle Nivolumab Opdivo®
10.02 Formulary Black Triangle Nusinersen Spinraza ®
08.02.04 Formulary Black Triangle Ocrelizumab Ocrevus®
03.01.01.01 Formulary Black Triangle Olodaterol Striverdi Respimat®
05.03.03.02 Formulary Black Triangle Ombitasvir/ paritaprevir/ ritonavir Viekirax®
08.01.05 Formulary Black Triangle Palbociclib Ibrance®
09.02.01.01 Formulary Black Triangle Patiromer sorbitex calcium Veltassa®
08.01.05 Formulary Black Triangle Pertuzumab/trastuzumab Phesgo®
08.01.05 Formulary Black Triangle Polatuzumab vedotin Polivy®
07.02.01 Non Formulary Black Triangle Prasterone Intrarosa®
05.03 Formulary Black Triangle Remdesivir Veklury®
08.01.05 Formulary Black Triangle Ribociclib Kisqali®
10.02 Formulary Black Triangle Risdiplam 
08.01.05 Formulary Black Triangle Rucaparib Rubraca®
02.11 Formulary Black Triangle Rurioctocog alfa pegol Adynovi®
10.01.03 Formulary Black Triangle Secukinumab Cosentyx®) (Rheumatology
13.05.03 Formulary Black Triangle Secukinumab Cosentyx®) (dermatology
06.01.02.03 Formulary Black Triangle Semaglutide Ozempic® /Rybelsus®
05.03.03.02 Formulary Black Triangle Simeprevir 
08.02.04 Formulary Black Triangle Siponimod Mayzent®
04.02.03 Formulary Black Triangle Sodium valproate 
04.08.01 Formulary Black Triangle Sodium Valproate 
09.02.01.01 Formulary Black Triangle Sodium zirconium cyclosilicate Lokelma
05.03.03.02 Formulary Black Triangle Sofosbuvir 
05.03.03.02 Formulary Black Triangle Sofosbuvir with velpatasvir Epclusa®
05.03.03.02 Formulary Black Triangle Sofosbuvir/velpatasvir/voxilaprevir Vosevi
08.01.05 Formulary Black Triangle Talimogene laherparepvec Imlygic®
01.04.02 Non Formulary Black Triangle Teduglutide Revestive®
03.07 Restricted Use Black Triangle Tezacaftor/ivacaftor Symkevi®
13.05.03 Formulary Black Triangle Tildrakizumab Ilumetri®
03.01.04 Formulary Black Triangle Tiotropium and olodaterol Spiolto Respimat®
01.05.03 Formulary Black Triangle Tofacitinib XELJANZ®
02.11 Formulary Black Triangle Turoctocog alfa pegol Esperoct®
03.01.02 Formulary Black Triangle Umeclidinium Incruse Ellipta®
03.01.04 Formulary Black Triangle Umeclidinium and vilanterol Anoro Ellipta®
10.01.03 Formulary Black Triangle Upadacitinib Rinvoq®
04.02.03 Non Formulary Black Triangle Valproate semisodium 
04.08.01 Non Formulary Black Triangle Valproic acid Convulex®
09.01 Formulary Black Triangle Vonicog alfa Veyvondi®
05.03.04 Formulary Black Triangle Zanamivir Dectova®
Southampton Joint Formulary